Treatment of colorectal cancer in China: Epidemiology, modern reality and ways of solving problems

8^th Euro Global Summit on Cancer Therapy

November 03-05, 2015 Valencia, Spain

Jin Gu

Beijing Cancer Hospital & Institute, PR China

Posters-Accepted Abstracts: J Cancer Sci Ther

Abstract :

Colorectal cancer (CRC) is the third most common cancer worldwide. Compared with a drop in western countries, the incidence of CRC is increasing in China for the past decade. Due to the lack of national registry system, data concerning CRC in China could only be estimated. Due to socio-economic disparities, such as medical conditions and skill levels, there is a wide variation in treating CRC. National Comprehensive Cancer Network (NCCN) guidelines and domestic guidelines are widely accepted by most oncologists. An update of â�?�?National Guideline of colorectal cancer treatmentâ�? is coming in 2015, which will bring in new breakthroughs from developed countries balanced with national reality. The implementation of these guidelines will provide a higher standardization of the treatment of CRC nationwide and will ensure that higher quality care will be available, especially in rural areas. International communications shorten the gaps between Chinese colorectal surgeons and their foreign colleagues. Continuous medical education policy has been advocated by the government, with regular tours of specialists and training program of multidisciplinary team. In this presentation, the current situation regarding CRC epidemiology, surgical treatment of rectal cancer and strategy to solve problems summarized.

Biography :

Email: zlgujin@126.com